|
Feb 23
|
Why Apellis Pharmaceuticals, Inc. (APLS) is the Most Oversold Pharma Stock to Buy According to Analysts
|
|
Feb 21
|
Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Feb 21
|
High Growth Tech Stocks In The United States To Watch
|
|
Feb 20
|
Is Apellis Pharmaceuticals (APLS) One of the Most Oversold Healthcare Stocks to Buy Now?
|
|
Feb 20
|
Apellis and Sobi Announce EMA Validation of Indication Extension Application for Aspaveli® (pegcetacoplan) for C3G and Primary IC-MPGN
|
|
Feb 18
|
Apellis Pharmaceuticals (APLS): Among Top Insider Stock Buys And Sells In January
|
|
Feb 14
|
Apellis Pharmaceuticals to Host Conference Call on February 28, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
|
|
Feb 13
|
Apellis Pharmaceuticals (NASDAQ:APLS investor one-year losses grow to 58% as the stock sheds US$231m this past week
|
|
Jan 3
|
Exploring 3 High Growth Tech Stocks In The United States
|